Last Updated: January 2026 · Independent review, may include affiliate links.
Quick Overview
Viz.ai is an AI care-coordination platform that helps hospital teams detect time-critical conditions from medical images and mobilize the right specialists in minutes. Focused on acute care such as stroke, it uses FDA-cleared algorithms to spot issues on CT, EKG, and echo scans, then pushes real-time alerts and secure chat to clinicians on mobile and desktop.
Core Features
- 50+ FDA-Cleared Algorithms — detect large vessel occlusions, intracranial hemorrhage, pulmonary embolism, AAA, and more in seconds from imaging and EHR data.
- Real-Time Alerts & Secure Comms — mobile notifications, secure chat, and team sync immediately after detection.
- Viz Assist Agents — multimodal AI that writes patient summaries, automates tasks, and assists documentation like a clinical co-pilot.
- Workflow Optimization — cuts transfers and delays, improves door-to-treatment times, and integrates with EHR and Microsoft systems.
- Scalable Deployment — used across roughly 2,000 hospitals with about 90% alert click-through from clinicians.
Use Cases
- Stroke & Neuro Teams — LVO detection, fast triage, and mobile alerts for thrombectomy.
- Hospitals & Networks — hub-spoke coordination and fewer futile transfers.
- Life Sciences & Research — patient access, trial enrollment, and care-gap closure.
- Broader Care Areas — cardio, oncology, and PE/AAA detection and coordination.
Pricing
Viz.ai is enterprise-grade and does not list public prices, which is typical for hospital-deployed platforms. It is sold through contracts with hospitals and health systems, and some modules tie into NTAP reimbursement (historically up to about $1,040 per use for Viz LVO). As of January 2026, teams request a demo or quote; value comes from faster treatment, better outcomes, and operational efficiency.
Pros & Cons
What we like:
- Proven to cut critical delays in stroke care.
- High clinician buy-in and engagement.
- Massive scale with real-world evidence.
- Viz Assist agents reduce administrative load.
- Mobile-first for on-the-go decisions.
- Expands beyond stroke into cardio and oncology.
Room for improvement:
- Enterprise pricing, not for small practices.
- Requires hospital integration effort.
- Focused mainly on the US market.
- No consumer access; professional-only.
FAQ
Is Viz.ai available to individual clinicians or consumers?
No—it is deployed at the hospital and health-system level and is not consumer-facing.
What conditions does Viz.ai detect?
It uses 50+ FDA-cleared algorithms for stroke, intracranial hemorrhage, pulmonary embolism, abdominal aortic aneurysm, and related acute conditions.
How is Viz.ai priced?
Pricing is contract-based per health system; some modules use NTAP reimbursement. Public self-serve pricing is not offered as of January 2026.
Related: explore more AI models & engines on aifreetool.site.
